555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

Wu, X; Liang, S; Chen, X; Hou, J; Wang, K; Wang, D; An, R; Zang, A; Li, X; Zhang, B; Qu, P; Duan, Wei; Yu, G; Yan, D; Wang, J; Yao, D; Wang, S; Zhao, W; Lou, H

File(s) not publicly available

555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

journal contribution

posted on 2024-07-31, 01:50 authored by X Wu, S Liang, X Chen, J Hou, K Wang, D Wang, R An, A Zang, X Li, B Zhang, P Qu, Wei DuanWei Duan, G Yu, D Yan, J Wang, D Yao, S Wang, W Zhao, H Lou

555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

History

Journal

Annals of Oncology

Volume

33

Pagination

S802-S802

Publisher DOI

https://doi.org/10.1016/j.annonc.2022.07.683

ISSN

0923-7534

Language

en

Publication classification

E3.1 Extract of paper

Publisher

Elsevier BV

Usage metrics

Keywords

Cancer Clinical Trials and Supportive Activities Uterine Cancer Clinical Research Women's Health 6.1 Pharmaceuticals

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

555P TQB2450 injection combined with anlotinib hydrochloride capsule in the treatment of advanced, recurrent or metastatic endometrial cancer: A multicohort, open label, multicenter phase II clinical trial - The TQB2450-II-08 trial

History

Journal

Volume

Pagination

Publisher DOI

ISSN

Language

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports